𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival

✍ Scribed by Gruenberger, T.; Arnold, D.; Rubbia-Brandt, L.


Book ID
123107499
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
558 KB
Volume
21
Category
Article
ISSN
0960-7404

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Bevacizumab improves pathologic response
✍ Dario Ribero; Huamin Wang; Matteo Donadon; Daria Zorzi; Melanie B. Thomas; Cathy πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 271 KB

## Abstract ## BACKGROUND. The current study evaluated the effect of bevacizumab added to fluoropyrimidine‐plus‐oxaliplatin (5FU/OX) chemotherapy for colorectal liver metastases (CLM) on the pathologic response and nontumorous liver histology. ## METHODS. A total of 105 consecutive patients trea